Roche presents new Alzheimer’s disease data from integrated pharmaceutical and diagnostics portfolio at AAIC 2026
Roche will showcase new trontinemab clinical data, Phase III prevention studies, neuroinflammatory research, and blood-based Alzheimer’s diagnostics including Elecsys® pTau217 and pTau181
























